$200M Singapore plant will be Amgen's first in Asia

01/18/2013 | Reuters

Amgen plans to invest about $200 million to construct a manufacturing plant at the Tuas Biomedical Park in Singapore. Work on the facility, Amgen's first in Asia, is expected to start within months. The plant's first products will be antibody drugs.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA